# FDA 483 - Lonza Guangzhou Pharmaceutical Ltd. - October 31, 2025

Source: https://www.globalkeysolutions.net/records/483/lonza-guangzhou-pharmaceutical-ltd/b3303a47-c752-44e7-a907-b9786d78d93e

> FDA 483 for Lonza Guangzhou Pharmaceutical Ltd. on October 31, 2025. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Lonza Guangzhou Pharmaceutical Ltd.
- Inspection Date: 2025-10-31
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [483 - 2026-10-27](https://www.globalkeysolutions.net/records/483/lonza-guangzhou-pharmaceutical-ltd/df52d74b-2836-4efe-b3f5-fa4993a002a2)

## Related Officers

- [David V. Ward](https://www.globalkeysolutions.net/people/david-v-ward/14bb7fc5-296b-4d14-bd3e-4c6ce5ac5cc2)
- [Wang Liquan](https://www.globalkeysolutions.net/people/wang-liquan/2bf621f0-0bbb-4939-9569-bf37cace7c0c)
- [Jose M. Cayuela](https://www.globalkeysolutions.net/people/jose-m-cayuela/3ee89bb5-4bba-493b-816f-31b8a9768025)

Company: https://www.globalkeysolutions.net/companies/lonza-guangzhou-pharmaceutical-ltd/eeb8d307-3663-4559-88cd-4e0696c0b556

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c